Home / Posts Tagged "Dr. V. Mohan"

Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time. Oral semaglutide will be a gamechanger for people with type 2 diabetes who prefer oral medications over injections. was

READ MORE

   Dr. V. Mohan, President, Madras Diabetes Research Foundation (MDRF) & Chairman, Dr. Mohan’s Diabetes Specialities Centre, has been ranked and recognised as Tamil Nadu’s topmost scientist-cum-researcher in a list compiled and published by Stanford University, Elsevier BV and SciTech Strategies. A team from Stanford University along

READ MORE

Boehringer Ingelheim Supports his Call to Recognize ‘June’ as Diabetes Control Month Dr. V. Mohan, Chairman & Chief Diabetologist Dr. Mohan’s Diabetes Specialities Centre, has made an urgent plea to all diabetes management organisations, institutions and people including doctors, hospitals, clinics, NGOs, Governments, and the public

READ MORE